Kala Pharmaceuticals Inc (KALA)
NASDAQ:KALA
Holding KALA?
Track your performance easily

Kala Pharmaceuticals (KALA) Ownership - Who Owns Kala Pharmaceuticals?

1,438 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$6319565

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
891,335Institution19.35%5,356,923
51,154Institution1.11%307,436
41,149Institution0.89%247,305
17,103Institution0.37%102,789
3,500Institution0.08%21,035
3,317Institution0.07%19,935
226Institution<0.01%1,358
46Institution<0.01%276
2Institution<0.01%12

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
41,149Institution0.89%247,305
17,103Institution0.37%102,789
3,500Institution0.08%21,035
3,317Institution0.07%19,935
226Institution<0.01%1,358
46Institution<0.01%276
2Institution<0.01%12

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
26,296Institution0.57%173,028
24,858Institution0.54%163,566

FAQ

Who Owns Kala Pharmaceuticals Inc (KALA)?
Currently, no data Available
What percentage of Kala Pharmaceuticals Inc (KALA) stock is held by institutional investors?
Currently, no data Available
What percentage of Kala Pharmaceuticals Inc (KALA) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Kala Pharmaceuticals Inc (KALA)?
Felix Baker owns the most shares of Kala Pharmaceuticals Inc (KALA).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis